Tobias Berg

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Andreas Lauritzen

Københavns Universitet

DENMARK

View details

Annette Raskov Kodahl

Odense University Hospital

DENMARK

View details

Thomas Christensen

Clinical research associate professor

University of Copenhagen

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tobias Berg

Research Interests

Contact this professor

Articles (8)

Real-world survival of Danish patients with HER2-positive metastatic breast cancer

Identifying recurrent breast cancer patients in national health registries using machine learning

A retrospective, non-interventional study of breast cancer patients diagnosed with ER+/HER2 negative, locally advanced or metastatic breast cancer treated with palbociclib in Denmark

A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients

First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG

Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2- metastatic breast cancer.

Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients

Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)

Collaborators (3)

Andreas Lauritzen

Annette Raskov Kodahl

Thomas Christensen

Make your next move.